Work

P2.04-004 IMpower010: A Phase III Study of Atezolizumab vs Best Supportive Care Following Adjuvant Chemotherapy in Completely Resected NSCLC

Year: 2017

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2017.11.017

Authors: E. Felip, H. Wakelee, E. Vallieres, C. Zhou, Y. Zuo, F. Xia, A. Sandler, N. Altorki

Institutions: Vall d'Hebron Hospital Universitari, Stanford Medicine, Stanford University, Tongji University, Shanghai Pulmonary Hospital, Roche (China), Genentech, NewYork–Presbyterian Hospital, Weill Cornell Medicine

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2769942443

FWCI:

Cites:

Cited by: 1

Related to: 10